About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Rapgef2tm1.1Hous
targeted mutation 1.1, Steven X Hou
MGI:4839105
Summary 7 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous involves: 129S1/Sv MGI:4839182
cn2
Cd19tm1(cre)Cgn/Cd19+
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
involves: 129P2/OlaHsd * 129S1/Sv MGI:4839186
cn3
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(VAV1-cre)1Graf/0
involves: 129S1/Sv MGI:4839188
cn4
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(Cd4-cre)1Cwi/0
involves: 129S1/Sv * C57BL/6 * CBA MGI:4839185
cn5
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(Mx1-cre)1Cgn/0
involves: 129S1/Sv * C57BL/6 * CBA MGI:4839184
cn6
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(CAG-cre/Esr1*)5Amc/0
involves: 129S1/Sv * C57BL/6 * CBA MGI:4839181
cn7
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(Cdh5-cre)7Mlia/0
involves: 129S1/Sv * FVB/N MGI:4839187


Genotype
MGI:4839182
hm1
Allelic
Composition
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Genetic
Background
involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rapgef2tm1.1Hous mutation (1 available); any Rapgef2 mutation (83 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 15% of tamoxifen-treated mice die at E18.5 to E20.5




Genotype
MGI:4839186
cn2
Allelic
Composition
Cd19tm1(cre)Cgn/Cd19+
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19tm1(cre)Cgn mutation (11 available); any Cd19 mutation (60 available)
Rapgef2tm1.1Hous mutation (1 available); any Rapgef2 mutation (83 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• mice exhibit normal adult hematopoiesis

immune system
N
• mice exhibit normal B cell and T cell development




Genotype
MGI:4839188
cn3
Allelic
Composition
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(VAV1-cre)1Graf/0
Genetic
Background
involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rapgef2tm1.1Hous mutation (1 available); any Rapgef2 mutation (83 available)
Tg(VAV1-cre)1Graf mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• mice exhibit normal adult hematopoiesis

immune system
N
• mice exhibit normal B cell and T cell development




Genotype
MGI:4839185
cn4
Allelic
Composition
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(Cd4-cre)1Cwi/0
Genetic
Background
involves: 129S1/Sv * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rapgef2tm1.1Hous mutation (1 available); any Rapgef2 mutation (83 available)
Tg(Cd4-cre)1Cwi mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• mice exhibit normal adult hematopoiesis

immune system
N
• mice exhibit normal B cell and T cell development




Genotype
MGI:4839184
cn5
Allelic
Composition
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(Mx1-cre)1Cgn/0
Genetic
Background
involves: 129S1/Sv * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rapgef2tm1.1Hous mutation (1 available); any Rapgef2 mutation (83 available)
Tg(Mx1-cre)1Cgn mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• pIpC-treated mice exhibit normal adult hematopoiesis

immune system
N
• pIpC-treated mice exhibit normal B cell and T cell development




Genotype
MGI:4839181
cn6
Allelic
Composition
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(CAG-cre/Esr1*)5Amc/0
Genetic
Background
involves: 129S1/Sv * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rapgef2tm1.1Hous mutation (1 available); any Rapgef2 mutation (83 available)
Tg(CAG-cre/Esr1*)5Amc mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• most mice treated with tamoxifen at E11.5 and E13.5 die E17.5 and E18.5 with remaining mice dying at E19.5 to E10.5
• however, mice treated with tamoxifen at E17.5 and E19.5 exhibit the same lethality as in similarly treated Rapgef2tm1.1Hous homozygotes

hematopoietic system
• mice treated with tamoxifen at E11.5 and E13.5 exhibit impaired fetal liver hematopoiesis with reduced differentiation of erythroid progenitor cells compared with similarly treated Rapgef2tm1.1Hous homozygotes
• at E16.5 in the livers of mice treated with tamoxifen at E11.5 and E13.5

cardiovascular system
• at E17.5, mice treated with tamoxifen at E11.5 and E13.5 lack major embryonic blood vessels unlike wild-type mice

growth/size/body
• in mice treated with tamoxifen at E17.5 and E19.5

liver/biliary system
• at E16.5 in mice treated with tamoxifen at E11.5 and E13.5

integument
• at E17.5 in mice treated with tamoxifen at E11.5 and E13.5




Genotype
MGI:4839187
cn7
Allelic
Composition
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(Cdh5-cre)7Mlia/0
Genetic
Background
involves: 129S1/Sv * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rapgef2tm1.1Hous mutation (1 available); any Rapgef2 mutation (83 available)
Tg(Cdh5-cre)7Mlia mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• mice exhibit normal adult hematopoiesis

immune system
N
• mice exhibit normal B cell and T cell development





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory